| Engineering islets from stem cells for advanced therapies of diabetes J Siehler, AK Blöchinger, M Meier, H Lickert Nature reviews Drug discovery 20 (12), 920-940, 2021 | 97 | 2021 |
| Point mutations in the PDX1 transactivation domain impair human β-cell development and function X Wang, M Sterr, I Burtscher, A Böttcher, J Beckenbauer, J Siehler, ... Molecular metabolism 24, 80-97, 2019 | 84 | 2019 |
| Inceptor counteracts insulin signalling in β-cells to control glycaemia Ansarullah, C Jain, FF Far, S Homberg, K Wissmiller, FG von Hahn, ... Nature 590 (7845), 326-331, 2021 | 67 | 2021 |
| Increasing gene editing efficiency for CRISPR-Cas9 by small RNAs in pluripotent stem cells A Shahryari, N Moya, J Siehler, X Wang, I Burtscher, H Lickert The CRISPR Journal 4 (4), 491-501, 2021 | 14 | 2021 |
| Generation of an INSULIN-H2B-Cherry reporter human iPSC line AK Blöchinger, J Siehler, K Wißmiller, A Shahryari, I Burtscher, H Lickert Stem Cell Research 45, 101797, 2020 | 13 | 2020 |
| Generation of a heterozygous C-peptide-mCherry reporter human iPSC line (HMGUi001-A-8) J Siehler, AK Blöchinger, M Akgün, X Wang, A Shahryari, A Geerlof, ... Stem Cell Research 50, 102126, 2021 | 6 | 2021 |
| Generation of a human iPSC line harboring a biallelic large deletion at the INK4 locus (HMGUi001-A-5) A Shahryari, N Moya, J Siehler, X Wang, AK Blöchinger, I Burtscher, ... Stem Cell Research 47, 101927, 2020 | 4 | 2020 |
| Author Correction: Inceptor counteracts insulin signalling in β-cells to control glycaemia Ansarullah, C Jain, FF Far, S Homberg, K Wissmiller, FG von Hahn, ... Nature 592 (7852), E1-E1, 2021 | 2 | 2021 |
| Pharmacological Targeting of the Actin Cytoskeleton to Drive Endocrinogenesis J Siehler, AK Blöchinger, H Lickert Trends in Pharmacological Sciences 41 (6), 384-386, 2020 | 1 | 2020 |
| Generation of a human induced pluripotent stem cell line (HMGUi002-A) from a healthy male individual X Wang, AR Malinowski, J Beckenbauer, J Siehler, A Bloechinger, ... Stem Cell Research 39, 101531, 2019 | 1 | 2019 |
| Inceptor binds to and directs insulin towards lysosomal degradation in β cells J Siehler, S Bilekova, P Chapouton, A Dema, P Albanese, S Tamara, ... Nature Metabolism, 1-17, 2024 | | 2024 |
| Inceptor counteracts insulin signalling in beta-cells to control glycaemia (vol 590, pg 326, 2021) Ansarullah, C Jain, FF Far, S Homberg, K Wissmiller, FG von Hahn, ... NATURE, 2021 | | 2021 |
